News and Events

Join us at our first Asia regulatory & pharmacovigilance workshop

Under

Pharma To Market looks forward to hosting you at our first-ever Pharmaceutical Regulatory Affairs & Pharmacovigilance Asia Workshop, happening on the 26th October 2018 in Singapore. This workshop is co-organised together with the Pharmaceutical Society of Singapore.

Do join us for a full-day workshop specially curated to provide participants in the…

Continue reading →

Pharma To Market look forward to catching up with our colleagues at ARCS ASC in Sydney

Under

We are pleased to bring their six members of our team to the annual ARCS Annual Scientific Conference in Sydney this month.  Joelle Chia, Pharma To Market’s Director of their South-East Asian operations will be speaking about regulatory affairs requirements in ASEAN and Daria Wain, Pharma To Market’s Regulatory Publishing…

Continue reading →

Pharma To Market participate in MTPConnect’s Bridge Initiative

Under

Pharma To Market’s Australian Directors Nick Ward and Johanna Hann are excited to have been accepted in to ‘The Bridge Program’ and attended the Sydney launch event in June.  The Bridge Program is an initiative of MTPConnect and aims to boost the commercial outputs of Australian pharmaceutical research, by improving…

Continue reading →

Pharma To Market Expansion into Asia

Under

Directors from Pharma To Market Pty Ltd and Ador Consulting Pte Ltd announce that the two companies have joined forces, resulting in the founding of Pharma To Market Pte Ltd, based in Singapore. Pharma To Market are pleased to announce their expansion into Asia with the opening of an office…

Continue reading →

RAPS Regulatory Convergence

Under

Pharma To Market are pleased to be exhibiting at and attending the RAPS Regulatory Convergence 2016 on 17-20 September 2016 in California, USA.

We are looking forward to meeting our fellow delegates from the USA and around the globe to explore how Pharma To Market can assist companies looking to enter…

Continue reading →

Copyright © 2018 Pharma to Market. All Rights Reserved.

Translate »